ORAPHARMA INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
FDA-approved drugs
openFDA · most recent- ARESTINFeb 16, 2001
Material events
SEC Form 8-K · most recentEvents the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/ASCHEDULE 13G/AFeb 14, 2003
- SC 13D/AFeb 11, 2003
- 15-12GFORM 15Feb 10, 2003
- SC 13DJan 23, 2003
- DEFM14AORAPHARMA, INC. DEFINITIVE PROXY STATEMENTJan 8, 2003
- PREM14AORAPHARM, INC.Nov 27, 2002
- 3INITIAL STATEMENT OF BENEFICIAL OWNERSHIPNov 21, 2002
- SC 13DSCHEDULE 13DNov 21, 2002
- 8-KORAPHARMA, INC.Nov 13, 2002
- DEFA14AORAPHARMA, INC.Nov 13, 2002
- 8-A12GFORM 8-A ORAPHARMANov 13, 2002
- DFAN14ADFAN 14ANov 13, 2002
- 10-QFORM 10-Q--ORAPHARMANov 6, 2002
- 8-A12GFORM 8-AAug 16, 2002
- 8-KFORM 8-KAug 16, 2002